SEARCH

SEARCH BY CITATION

References

  • 1
    Lieberman P. Anaphylaxis and anaphylactoid reactions. In: AdkinsonFNJ, Yunginger JohnW, Busse WilliamW, Bochner BruceS, Holgate StephenT, SimonsF, EstelleR, editors. Middleton’s allergy principles and practice. Philadelphia, PA: Mosby, 2003:14971522.
  • 2
    Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olmsted County, a population-based study. J Allergy Clin Immunol 1999;104:452456.
  • 3
    Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS, Vaccine Safety Datalink Team. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 2004;113:536542.
  • 4
    Mulla ZD, Simon MR. Hospitalizations for anaphylaxis in Florida: epidemiologic analysis of a population-based dataset. Int Arch Allergy Immunol 2007;144:128136.
  • 5
    Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med 2004;164:317319.
  • 6
    Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004;34:285290.
  • 7
    Pumphrey RS Fatal anaphylaxis in the UK, 1992–2001. Novartis Found Symp. 2004;257:116128; discussion 128–32, 157–60, 276–85.
  • 8
    Grigg CM, Jones KT. Florida population estimates. In: Florida vital statistics Annual Report 2005. Jacksonville, FL: State of Florida Department of Health. http://www.flpublichealth.com/VSBOOK/pdf/2005/Population.pdf; accessed 9 May 2008.
  • 9
    Blalock HM Jr. Social statistics. 2nd edn. NY: McGraw-Hill Book Co, 1972, 238239.
  • 10
    Koepsell TD, Weiss NS Epidemiologic methods: studying the occurrence of illness. New York: Oxford University Press, 2003, p. 64.
  • 11
    Rothman KJ Epidemiology: an introduction. New York: Oxford University Press, 2002:132.
  • 12
    Dean AG, Sullivan KM, Soe MM. Open EPI: Open Source Epidemiologic Statistics for Public Health, version 2.2, Emory University, Atlanta, GA, USA. http://www.openepi.com; accessed 9 May 2008.
  • 13
    Daniel WW Death rates and ratios. In: Biostatistics: a foundation for analysis in the health sciences, 5th edn. New York: John Wiley & Sons Inc, 1991:632636.
  • 14
    Office for National Statistics. http://www.statistics.gov.uk/StatBase; accessed 9 May 2008.
  • 15
    Swiss Population Estimate. http://www.cartage.org.lb; accessed 9 May 2008.
  • 16
    Historic Population of Olmsted County and the City of Rochester dating from 1860 to 2000. http://www.co.olmsted.mn.us/upload_dir/demographics/historicpopulation.pdf; accessed 9 May 2008.
  • 17
    Weiler JM. Anaphylaxis in the general population: a frequent and occasionally fatal disorder that is underrecognized. J Allergy Clin Immunol. 1999;104 (2 Pt 1):271273.
  • 18
    Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999–2006. J Allergy Clin Immunol 2007;119:10181019.
  • 19
    Salter J, Mehra S, Cairns JT, Sussman G, Vadas P. A study of 32 food-induced anaphylaxis deaths in Ontario; 1986–2000. http://www.anaphylaxis.org/content/programs/programs_research_deaths.asp; accessed 9 May 2008.
  • 20
    Foucard T, Yman IM, Nordvall L. Färre dödsfall och livshotande födoämnesreaktioner. Läkarkårens rapportering har lett till effektiva åtgärder [Reduced number of fatal and life-threatening reactions to food. Reporting by the medical profession has resulted in effective measures]. Lakartidningen 2005;102:34653468.
  • 21
    Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 2001;161:1521.
  • 22
    Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004;4:285290.
  • 23
    Simon MR, Mulla ZD. Hospitalizations for anaphylaxis in Florida: analysis of month of discharge. Int Arch Allergy Immunol 2008;146:8990.